{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:19:51Z","timestamp":1791724791609,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024MH285"],"award-info":[{"award-number":["ZR2024MH285"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024QH183"],"award-info":[{"award-number":["ZR2024QH183"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["W202406120614"],"award-info":[{"award-number":["W202406120614"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304398"],"award-info":[{"award-number":["82304398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404526"],"award-info":[{"award-number":["82404526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114429","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:48:34Z","timestamp":1763646514000},"page":"114429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Engineered potent DC vaccine enables closer DC-T cell contact to trigger personalized antitumor immunity"],"prefix":"10.1016","volume":"389","author":[{"given":"Ying","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114429_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2024","key":"10.1016\/j.jconrel.2025.114429_bb0010","first-page":"47","article-title":"Cancer incidence and mortality in China","volume":"4","author":"Han","year":"2022","journal-title":"Journal of the National Cancer Center"},{"key":"10.1016\/j.jconrel.2025.114429_bb0015","first-page":"258","article-title":"Emerging strategies for treating metastasis","volume":"2","author":"Esposito","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2025.114429_bb0020","first-page":"215","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines, nature reviews","volume":"18","author":"Blass","year":"2021","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114429_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.701777","article-title":"Personalized Neoantigen-pulsed DC vaccines: advances in clinical applications","volume":"11","author":"Tang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2025.114429_bb0030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nri2173","article-title":"Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting","volume":"7","author":"Tacken","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114429_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","article-title":"Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination with Extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial","volume":"9","author":"Liau","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2025.114429_bb0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ygyno.2021.07.003","article-title":"Dendritic cell-based immunotherapy (DCVAC\/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): a randomized, open-label, phase 2 trial","volume":"162","author":"Cibula","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114429_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114429_bb0050","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s41467-024-45358-0","article-title":"Adjuvant dendritic cell therapy in stage IIIB\/C melanoma: the MIND-DC randomized phase III trial","volume":"15","author":"Bol","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114429_bb0055","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2217\/fon.12.125","article-title":"Dendritic cell-based vaccines: barriers and opportunities","volume":"8","author":"Cintolo","year":"2012","journal-title":"Future oncology (London, England)"},{"key":"10.1016\/j.jconrel.2025.114429_bb0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114429_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114429_bb0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm0597-558","article-title":"Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells","volume":"3","author":"Gong","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114429_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105511","article-title":"Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis","volume":"25","author":"Diao","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2025.114429_bb0080","series-title":"Hyperglycosylation of Prosaposin in Tumor DCs Promotes Immune Escape in cancer, bioRxiv\u202f: The Preprint Server for Biology","author":"Sharma","year":"2023"},{"key":"10.1016\/j.jconrel.2025.114429_bb0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41551-024-01285-5","article-title":"Antitumour vaccination via the targeted proteolysis of antigens isolated from tumour lysates","volume":"9","author":"Zhao","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114429_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122104","article-title":"Regulating T-cell metabolic reprogramming and blocking PD-1 co-promote personalized postoperative autologous nanovaccines","volume":"297","author":"Chang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114429_bb0095","doi-asserted-by":"crossref","first-page":"22213","DOI":"10.1021\/acsami.1c03709","article-title":"Lymph node delivery strategy enables the activation of cytotoxic T lymphocytes and natural killer cells to augment Cancer immunotherapy","volume":"13","author":"Jiang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114429_bb0100","first-page":"3384","article-title":"Rapid expansion of highly functional antigen-specific T cells from patients with melanoma by nanoscale artificial antigen-presenting cells, clinical cancer research\u202f: an official journal of the American association for","volume":"26","author":"Ichikawa","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114429_bb0105","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/acs.chemrev.7b00157","article-title":"Engineering the surface of therapeutic \u201cliving\u201d cells","volume":"118","author":"Park","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.114429_bb0110","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acsbiomaterials.7b00514","article-title":"Surface engineering for cell-based therapies: techniques for manipulating mammalian cell surfaces","volume":"4","author":"Abbina","year":"2018","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.jconrel.2025.114429_bb0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41467-023-44308-6","article-title":"T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors","volume":"15","author":"Middelburg","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114429_bb0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41557-020-00587-w","article-title":"Metabolic glycan labelling for cancer-targeted therapy","volume":"12","author":"Wang","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2025.114429_bb0125","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41563-020-0680-1","article-title":"Metabolic labeling and targeted modulation of dendritic cells","volume":"19","author":"Wang","year":"2020","journal-title":"Nat. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:40:38Z","timestamp":1781325638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925010430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"alternative-id":["S0168365925010430"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114429","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered potent DC vaccine enables closer DC-T cell contact to trigger personalized antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114429"}}